ALLR: Allarity Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Allarity Therapeutics Inc (ALLR).
$5.19M Market Cap.
ALLR Market Cap. (MRY)
ALLR Shares Outstanding (MRY)
ALLR Assets (MRY)
Total Assets
$22.65M
Total Liabilities
$10.84M
Total Investments
$0
ALLR Income (MRY)
Revenue
$0
Net Income
-$24.52M
Operating Expense
$27.24M
ALLR Cash Flow (MRY)
CF Operations
-$17.35M
CF Investing
-$298.00K
CF Financing
$36.79M
ALLR Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $22,650,000 (90.95%) | $11,862,000 (-18.44%) | $14,544,000 (-70.70%) | $49,633,000 (48.59%) |
Assets Current | $22,341,000 (1033.49%) | $1,971,000 (-60.33%) | $4,968,000 (-76.79%) | $21,404,000 (1148.05%) |
Assets Non-Current | $309,000 (-96.88%) | $9,891,000 (3.29%) | $9,576,000 (-66.08%) | $28,229,000 (-10.92%) |
Goodwill & Intangible Assets | $0 (0%) | $9,871,000 (3.37%) | $9,549,000 (-66.06%) | $28,135,000 (-7.73%) |
Shareholders Equity | $11,811,000 (529.33%) | -$2,751,000 (-2334.51%) | -$113,000 (-100.62%) | $18,152,000 (-25.73%) |
Property Plant & Equipment Net | $309,000 (1445.00%) | $20,000 (-25.93%) | $27,000 (-71.28%) | $94,000 (-73.30%) |
Cash & Equivalents | $19,533,000 (11666.87%) | $166,000 (-91.82%) | $2,029,000 (-89.62%) | $19,555,000 (6462.08%) |
Accumulated Other Comprehensive Income | -$354,000 (13.87%) | -$411,000 (43.00%) | -$721,000 (-20.17%) | -$600,000 (-143.64%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $350,000 (-58.58%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $350,000 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,182,000 (-50.31%) | $8,416,000 (34.63%) | $6,251,000 (795.56%) | $698,000 (-67.01%) |
Accumulated Retained Earnings (Deficit) | -$118,966,000 (-25.96%) | -$94,451,000 (-14.42%) | -$82,550,000 (-24.15%) | -$66,492,000 (-66.88%) |
Tax Assets | $770,000 (-5.52%) | $815,000 (3.30%) | $789,000 (-5.85%) | $838,000 (-7.71%) |
Tax Liabilities | $74,000 (-85.35%) | $505,000 (29.49%) | $390,000 (-80.70%) | $2,021,000 (-7.80%) |
Total Debt | $1,350,000 (3.85%) | $1,300,000 (-65.19%) | $3,735,000 (243.92%) | $1,086,000 (-59.28%) |
Debt Current | $1,350,000 (3.85%) | $1,300,000 (-50.98%) | $2,652,000 (2606.12%) | $98,000 (-93.55%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $1,083,000 (9.62%) | $988,000 (-13.86%) |
Total Liabilities | $10,839,000 (-25.83%) | $14,613,000 (15.48%) | $12,654,000 (-58.98%) | $30,849,000 (244.14%) |
Liabilities Current | $10,839,000 (-23.49%) | $14,167,000 (26.24%) | $11,222,000 (-45.84%) | $20,719,000 (274.46%) |
Liabilities Non-Current | $0 (0%) | $446,000 (-68.85%) | $1,432,000 (-85.86%) | $10,130,000 (195.25%) |
ALLR Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $11,442,000 (14.12%) | $10,026,000 (0.64%) | $9,962,000 (-19.40%) | $12,360,000 (201.39%) |
Research & Development Expense | $6,096,000 (-14.18%) | $7,103,000 (2.50%) | $6,930,000 (-51.18%) | $14,196,000 (236.56%) |
Operating Expenses | $27,241,000 (59.03%) | $17,129,000 (-50.30%) | $34,463,000 (29.77%) | $26,556,000 (219.22%) |
Interest Expense | $653,000 (31.12%) | $498,000 (123.32%) | $223,000 (-87.92%) | $1,846,000 (476.88%) |
Income Tax Expense | -$381,000 (-559.04%) | $83,000 (105.46%) | -$1,521,000 (-1243.61%) | $133,000 (-32.83%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$24,515,000 (-105.99%) | -$11,901,000 (25.89%) | -$16,058,000 (39.74%) | -$26,648,000 (-302.72%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$24,515,000 (-105.99%) | -$11,901,000 (25.89%) | -$16,058,000 (39.74%) | -$26,648,000 (-303.64%) |
Preferred Dividends Income Statement Impact | $639,000 (-92.50%) | $8,515,000 (70.54%) | $4,993,000 (0%) | $0 (0%) |
Net Income Common Stock | -$25,154,000 (-23.21%) | -$20,416,000 (3.02%) | -$21,051,000 (21.00%) | -$26,648,000 (-303.64%) |
Weighted Average Shares | $1,606,989 (47373.83%) | $3,385 (30672.73%) | $11 (37.50%) | $8 (100.00%) |
Weighted Average Shares Diluted | $1,606,989 (47373.83%) | $3,385 (30672.73%) | $11 (37.50%) | $8 (100.00%) |
Earning Before Interest & Taxes (EBIT) | -$24,243,000 (-114.16%) | -$11,320,000 (34.78%) | -$17,356,000 (29.64%) | -$24,669,000 (-305.47%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$27,241,000 (-59.03%) | -$17,129,000 (50.30%) | -$34,463,000 (-29.77%) | -$26,556,000 (-219.22%) |
ALLR Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$298,000 (0%) | $0 (0%) | $791,000 (-21.29%) | $1,005,000 (33600.00%) |
Net Cash Flow from Financing | $36,792,000 (234.62%) | $10,995,000 (938.67%) | -$1,311,000 (-103.88%) | $33,818,000 (460.55%) |
Net Cash Flow from Operations | -$17,352,000 (-36.15%) | -$12,745,000 (24.21%) | -$16,817,000 (-12.97%) | -$14,886,000 (-105.30%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $19,142,000 (1193.83%) | -$1,750,000 (89.91%) | -$17,337,000 (-186.96%) | $19,937,000 (1732.84%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$298,000 (0%) | $0 (0%) | $791,000 (-21.29%) | $1,005,000 (33600.00%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | -$2,649,000 (-364.90%) | $1,000,000 (3.20%) | $969,000 (-62.04%) |
Issuance (Purchase) of Equity Shares | $37,354,000 (121.09%) | $16,895,000 (0%) | $0 (0%) | $34,890,000 (842.21%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $225,000 (299.12%) | -$113,000 (40.21%) | -$189,000 (72.21%) | -$680,000 (-13500.00%) |
Share Based Compensation | $407,000 (673.24%) | -$71,000 (-104.05%) | $1,752,000 (-72.49%) | $6,368,000 (933.77%) |
Depreciation Amortization & Accretion | $9,000 (-75.68%) | $37,000 (-38.33%) | $60,000 (-43.40%) | $106,000 (23.26%) |
ALLR Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -263.80% (-132.16%) | 820.30% (334.10%) | -350.40% (-180.10%) | -125.10% (-303.55%) |
Return on Average Assets (ROAA) | -117.20% (25.59%) | -157.50% (-63.04%) | -96.60% (-50.47%) | -64.20% (-216.26%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 312.30% (145.52%) | 127.20% (-44.23%) | 228.10% (-17.05%) | 275.00% (-63.50%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.07 (-36.36%) | -0.06 (58.65%) | -0.13 (94.63%) | -2.48 |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 0.44 (148.08%) | -0.91 (96.58%) | -26.68 (-677.90%) | 4.62 |
Debt to Equity Ratio (D/E) | 0.92 (117.28%) | -5.31 (95.26%) | -111.98 (-6691.05%) | 1.7 (362.94%) |
Earnings Per Share (EPS) | -15.65 (99.74%) | -6,031.31 (99.68%) | -1,856,070.56 (47.27%) | -3,519,635.2 (-106.40%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -10.98 (99.71%) | -3,765.14 (99.73%) | -1,412,978.31 (22.94%) | -1,833,685.6 (1.74%) |
Book Value Per Share (BVPS) | 7.35 (100.90%) | -812.7 (91.84%) | -9,962.97 (-100.42%) | 2,397,886.39 (-61.86%) |
Tangible Assets Book Value Per Share (TABVPS) | 14.1 (-97.60%) | 588.18 (-99.87%) | 440,398.52 (-84.49%) | 2,839,894.32 (279.08%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 0 (0%) | -3 |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.49 (344.06%) | -0.2 (-2144.44%) | -0.01 (99.72%) | -3.19 |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 2.06 (1382.73%) | 0.14 (-68.62%) | 0.44 (-57.12%) | 1.03 (233.23%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$17,650,000 (-38.49%) | -$12,745,000 (20.47%) | -$16,026,000 (-15.45%) | -$13,881,000 (-91.36%) |
Enterprise Value (EV) | -$11,938,703 (-623.57%) | $2,280,257 (1377.35%) | $154,348 (-99.80%) | $78,331,810 |
Earnings Before Tax (EBT) | -$24,896,000 (-110.66%) | -$11,818,000 (32.77%) | -$17,579,000 (33.70%) | -$26,515,000 (-314.04%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$24,234,000 (-114.78%) | -$11,283,000 (34.77%) | -$17,296,000 (29.59%) | -$24,563,000 (-309.52%) |
Invested Capital | -$6,372,000 (42.29%) | -$11,042,000 (-144.24%) | -$4,521,000 (74.44%) | -$17,690,000 (-6919.84%) |
Working Capital | $11,502,000 (194.31%) | -$12,196,000 (-95.01%) | -$6,254,000 (-1012.99%) | $685,000 (117.94%) |
Tangible Asset Value | $22,650,000 (1037.62%) | $1,991,000 (-60.14%) | $4,995,000 (-76.77%) | $21,498,000 (638.26%) |
Market Capitalization | $5,187,297 (106.48%) | $2,512,257 (-16.66%) | $3,014,348 (-96.40%) | $83,782,810 |
Average Equity | $9,534,750 (483.11%) | -$2,488,750 (-141.42%) | $6,008,000 (-71.79%) | $21,295,500 (0.15%) |
Average Assets | $21,470,000 (65.58%) | $12,966,250 (-40.52%) | $21,799,750 (-47.49%) | $41,518,000 (27.73%) |
Invested Capital Average | -$7,762,250 (12.75%) | -$8,896,250 (-16.92%) | -$7,608,750 (15.19%) | -$8,971,000 (-1010.96%) |
Shares | 4,433,587 (58252.03%) | 7,598 (63216.67%) | 12 (20.00%) | 10 (0.00%) |
